BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sattar N, McCarey DW, Capell H, McInnes IB. Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation. 2003;108:2957-2963. [PMID: 14676136 DOI: 10.1161/01.cir.0000099844.31524.05] [Cited by in Crossref: 577] [Cited by in F6Publishing: 202] [Article Influence: 33.9] [Reference Citation Analysis]
Number Citing Articles
1 Meissner Y, Zink A, Kekow J, Rockwitz K, Liebhaber A, Zinke S, Gerhold K, Richter A, Listing J, Strangfeld A. Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis. Arthritis Res Ther 2016;18:183. [PMID: 27495156 DOI: 10.1186/s13075-016-1077-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
2 Nursal AF, Kaya S, Sezer O, Karakus N, Yigit S. MTHFR gene C677T and A1298C variants are associated with FMF risk in a Turkish cohort. J Clin Lab Anal 2018;32. [PMID: 28543752 DOI: 10.1002/jcla.22259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Ristić GG, Subota V, Lepić T, Stanisavljević D, Glišić B, Ristić AD, Petronijević M, Stefanović DZ. Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis and Low Cardiovascular Risk: The Role of von Willebrand Factor Activity. PLoS One 2015;10:e0130462. [PMID: 26247590 DOI: 10.1371/journal.pone.0130462] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ruiz-Limon P, Ortega-Castro R, Barbarroja N, Perez-Sanchez C, Jamin C, Patiño-Trives AM, Luque-Tevar M, Ibáñez-Costa A, Perez-Sanchez L, de la Rosa IA, Abalos-Aguilera M, Jimenez-Gomez Y, Calvo-Gutierrez J, Font P, Escudero-Contreras A, Alarcon-Riquelme ME, Collantes-Estevez E, López-Pedrera C; PRECISESADS Clinical Consortium and Flow Cytometry Study Group. Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis. Front Immunol 2019;10:1111. [PMID: 31169830 DOI: 10.3389/fimmu.2019.01111] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
5 Krishnan E, Lingala VB, Singh G. Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis. Circulation 2004;110:1774-9. [PMID: 15381644 DOI: 10.1161/01.CIR.0000142864.83780.81] [Cited by in Crossref: 80] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
6 Breda L, Di Marzio D, Giannini C, Gaspari S, Nozzi M, Scarinci A, Chiarelli F, Mohn A. Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis. Clin Res Cardiol 2013;102:63-71. [PMID: 22885951 DOI: 10.1007/s00392-012-0496-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
7 Dessein PH, Joffe BI, Singh S. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 2005;7:R634-43. [PMID: 15899050 DOI: 10.1186/ar1717] [Cited by in Crossref: 150] [Cited by in F6Publishing: 135] [Article Influence: 9.4] [Reference Citation Analysis]
8 Morris G, Berk M, Walder K, Maes M. Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med. 2015;13:28. [PMID: 25856766 DOI: 10.1186/s12916-014-0259-2] [Cited by in Crossref: 96] [Cited by in F6Publishing: 76] [Article Influence: 16.0] [Reference Citation Analysis]
9 Lee SH, Choi H, Cho BL, An AR, Seo YG, Jin HS, Oh SM, Jang SH. Relationship between Metabolic Syndrome and Rheumatoid Arthritis. Korean J Fam Med 2016;37:44-50. [PMID: 26885322 DOI: 10.4082/kjfm.2016.37.1.44] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
10 Wagan AA, Mahmud TE, Rasheed A, Zafar ZA, Rehman AU, Ali A. Cardiovascular risk score in Rheumatoid Arthritis. Pak J Med Sci 2016;32:534-8. [PMID: 27375684 DOI: 10.12669/pjms.323.9779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Tam LS, Tomlinson B, Chu TT, Li TK, Li EK. Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis. Clin Rheumatol. 2007;26:1495-1498. [PMID: 17237906 DOI: 10.1007/s10067-007-0539-8] [Cited by in Crossref: 135] [Cited by in F6Publishing: 121] [Article Influence: 9.6] [Reference Citation Analysis]
12 Liu L, Lv G, Ning C, Yang YE, Zhu J. Therapeutic effects of 1,25-dihydroxyvitamin D3 on diabetes-induced liver complications in a rat model. Exp Ther Med 2016;11:2284-92. [PMID: 27284312 DOI: 10.3892/etm.2016.3242] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
13 Undas A, Gissel M, Kwasny-Krochin B, Gluszko P, Mann KG, Brummel-Ziedins KE. Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition. Thromb Haemost 2010;104:224-30. [PMID: 20593110 DOI: 10.1160/TH10-02-0091] [Cited by in Crossref: 31] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
14 Emery P, Keystone E, Tony HP, Cantagrel A, van Vollenhoven R, Sanchez A, Alecock E, Lee J, Kremer J. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Ann Rheum Dis 2008;67:1516-23. [PMID: 18625622 DOI: 10.1136/ard.2008.092932] [Cited by in Crossref: 737] [Cited by in F6Publishing: 616] [Article Influence: 56.7] [Reference Citation Analysis]
15 Makrilakis K, Fragiadaki K, Smith J, Sfikakis PP, Kitas GD. Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockade. Clin Rheumatol. 2015;34:419-427. [PMID: 24912961 DOI: 10.1007/s10067-014-2704-1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.1] [Reference Citation Analysis]
16 García-Bermúdez M, López-Mejías R, González-Juanatey C, Corrales A, Castañeda S, Ortiz AM, Miranda-Filloy JA, Gómez-Vaquero C, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, Blanco R, Llorca J, Martín J, González-Gay MA. CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in Spanish rheumatoid arthritis patients. DNA Cell Biol 2013;32:28-33. [PMID: 23088220 DOI: 10.1089/dna.2012.1836] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
17 Stamatelopoulos KS, Kitas GD, Papamichael CM, Chryssohoou E, Kyrkou K, Georgiopoulos G, Protogerou A, Panoulas VF, Sandoo A, Tentolouris N. Atherosclerosis in rheumatoid arthritis versus diabetes: a comparative study. Arterioscler Thromb Vasc Biol. 2009;29:1702-1708. [PMID: 19608975 DOI: 10.1161/atvbaha.109.190108] [Cited by in Crossref: 127] [Cited by in F6Publishing: 48] [Article Influence: 10.6] [Reference Citation Analysis]
18 Zampeli E, Protogerou A, Stamatelopoulos K, Fragiadaki K, Katsiari CG, Kyrkou K, Papamichael CM, Mavrikakis M, Nightingale P, Kitas GD, Sfikakis PP. Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study. Arthritis Res Ther 2012;14:R44. [PMID: 22390577 DOI: 10.1186/ar3757] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
19 Candan Z, Akdoğan A, Karadağ Ö, Kalyoncu U, Şahin A, Bilgen Ş, Çalgüneri M, Kiraz S, Ertenli A. Serum lipid changes and insulin resistance in familial Mediterranean fever. Eur J Rheumatol 2014;1:140-3. [PMID: 27708899 DOI: 10.5152/eurjrheumatol.2014.140045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
20 Burmester GR, Gordon KB, Rosenbaum JT, Arikan D, Lau WL, Li P, Faccin F, Panaccione R. Long-Term Safety of Adalimumab in 29,967 Adult Patients From Global Clinical Trials Across Multiple Indications: An Updated Analysis. Adv Ther 2020;37:364-80. [PMID: 31748904 DOI: 10.1007/s12325-019-01145-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
21 Buckley CD, Rainger GE, Nash GB, Raza K. Endothelial cells, fibroblasts and vasculitis. Rheumatology (Oxford) 2005;44:860-3. [PMID: 15644388 DOI: 10.1093/rheumatology/keh542] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
22 Ludvigsson JF, de Faire U, Ekbom A, Montgomery SM. Vascular disease in a population-based cohort of individuals hospitalised with coeliac disease. Heart. 2007;93:1111-1115. [PMID: 17277354 DOI: 10.1136/hrt.2006.097097] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
23 Kinne RW, Stuhlmüller B, Burmester GR. Cells of the synovium in rheumatoid arthritis. Macrophages. Arthritis Res Ther. 2007;9:224. [PMID: 18177511 DOI: 10.1186/ar2333] [Cited by in Crossref: 185] [Cited by in F6Publishing: 175] [Article Influence: 14.2] [Reference Citation Analysis]
24 Peters MJ, Vis M, van Halm VP, Wolbink GJ, Voskuyl AE, Lems WF, Dijkmans BA, Twisk JW, de Koning MH, van de Stadt RJ, Nurmohamed MT. Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis. Ann Rheum Dis 2007;66:958-61. [PMID: 17314120 DOI: 10.1136/ard.2006.059691] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 4.9] [Reference Citation Analysis]
25 Meek IL, Vonkeman HE, van de Laar MA. Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature. BMC Musculoskelet Disord. 2014;15:142. [PMID: 24779371 DOI: 10.1186/1471-2474-15-142] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.1] [Reference Citation Analysis]
26 Dessein PH, Woodiwiss AJ, Joffe BI, Norton GR. Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis. BMC Cardiovasc Disord 2007;7:31. [PMID: 17967187 DOI: 10.1186/1471-2261-7-31] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
27 Urban MH, Ay L, Funk GC, Burghuber OC, Eickhoff P, Wolzt M, Valipour A. Insulin resistance may contribute to vascular dysfunction in patients with chronic obstructive pulmonary disease. Wien Klin Wochenschr 2014;126:106-12. [PMID: 24343042 DOI: 10.1007/s00508-013-0478-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
28 McKellar GE, McCarey DW, Sattar N, McInnes IB. Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 2009;6:410-7. [PMID: 19421244 DOI: 10.1038/nrcardio.2009.57] [Cited by in Crossref: 169] [Cited by in F6Publishing: 148] [Article Influence: 14.1] [Reference Citation Analysis]
29 Ferraz-Amaro I, Rueda-Gotor J, Genre F, Corrales A, Blanco R, Portilla V, González Mazón I, Llorca J, Expósito R, Vicente EF, Quevedo-Abeledo JC, Rodríguez-Lozano C, Ortega-Castro R, Ladehesa-Pineda ML, Fernández-Carballido C, Martínez-Vidal MP, Castro-Corredor D, Anino-Fernández J, García Vivar ML, Galíndez-Agirregoikoa E, Peiteado D, Plasencia-Rodríguez C, Montes Perez E, Fernández Díaz C, Castañeda S, González-Gay MÁ. Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis. Ther Adv Musculoskelet Dis 2021;13:1759720X211033755. [PMID: 34377161 DOI: 10.1177/1759720X211033755] [Reference Citation Analysis]
30 Rodríguez-Rodríguez L, López-Mejías R, García-Bermúdez M, González-Juanatey C, González-Gay MA, Martín J. Genetic markers of cardiovascular disease in rheumatoid arthritis. Mediators Inflamm 2012;2012:574817. [PMID: 22927710 DOI: 10.1155/2012/574817] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
31 Pandey PK, Swami A, Biswas TK, Thakuria R. Prevalence of Metabolic Syndrome in Treatment Naïve Rheumatoid Arthritis and Correlation With Disease Parameters. Arch Rheumatol 2017;32:46-52. [PMID: 30375525 DOI: 10.5606/ArchRheumatol.2017.5949] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Quyyumi AA. Inflamed Joints and Stiff Arteries: Is Rheumatoid Arthritis a Cardiovascular Risk Factor? Circulation 2006;114:1137-9. [DOI: 10.1161/circulationaha.106.648139] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
33 Curran SA, Hollan I, Erridge C, Lappin DF, Murray CA, Sturfelt G, Mikkelsen K, Førre OT, Almdahl SM, Fagerhol MK, Goodyear CS, Riggio MP. Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis. PLoS One 2014;9:e98627. [PMID: 24874661 DOI: 10.1371/journal.pone.0098627] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
34 Ismail M, Hasan H, El-Orfali Y, Ismail H, Khawaja G. Anti-Inflammatory, Antioxidative, and Hepatoprotective Effects of Trans Δ9-Tetrahydrocannabinol/Sesame Oil on Adjuvant-Induced Arthritis in Rats. Evid Based Complement Alternat Med 2018;2018:9365464. [PMID: 30046349 DOI: 10.1155/2018/9365464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Hitchon CA, El-Gabalawy HS. Oxidation in rheumatoid arthritis. Arthritis Res Ther 2004;6:265-78. [PMID: 15535839 DOI: 10.1186/ar1447] [Cited by in Crossref: 373] [Cited by in F6Publishing: 294] [Article Influence: 21.9] [Reference Citation Analysis]
36 Di Minno MN, Peluso R, Iervolino S, Lupoli R, Russolillo A, Tarantino G, Scarpa R. Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study. Arthritis Res Ther 2012;14:R211. [PMID: 23036698 DOI: 10.1186/ar4049] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
37 Bonek K, Głuszko P. Cardiovascular risk assessment in rheumatoid arthritis - controversies and the new approach. Reumatologia 2016;54:128-35. [PMID: 27504023 DOI: 10.5114/reum.2016.61214] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
38 Di Minno MN, Iervolino S, Peluso R, Scarpa R, Di Minno G; CaRRDs study group. Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs. Arterioscler Thromb Vasc Biol 2011;31:705-12. [PMID: 21212403 DOI: 10.1161/ATVBAHA.110.214585] [Cited by in Crossref: 78] [Cited by in F6Publishing: 25] [Article Influence: 7.8] [Reference Citation Analysis]
39 Lacaille D, Avina-Zubieta JA, Sayre EC, Abrahamowicz M. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population-closing the mortality gap. Ann Rheum Dis 2017;76:1057-63. [PMID: 28031164 DOI: 10.1136/annrheumdis-2016-209562] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 14.0] [Reference Citation Analysis]
40 Herbrig K, Haensel S, Oelschlaegel U, Pistrosch F, Foerster S, Passauer J. Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann Rheum Dis 2006;65:157-63. [PMID: 15975971 DOI: 10.1136/ard.2005.035378] [Cited by in Crossref: 96] [Cited by in F6Publishing: 87] [Article Influence: 6.0] [Reference Citation Analysis]
41 Sillen M, Declerck PJ. Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review. Int J Mol Sci 2021;22:3670. [PMID: 33916027 DOI: 10.3390/ijms22073670] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Gonzalez-juanatey C, Gonzalez-gay MA. Rheumatoid Arthritis and Accelerated Atherogenesis. Circulation 2004;109. [DOI: 10.1161/01.cir.0000132731.43071.4f] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Kim Y, Lobatto ME, Kawahara T, Lee Chung B, Mieszawska AJ, Sanchez-Gaytan BL, Fay F, Senders ML, Calcagno C, Becraft J, Tun Saung M, Gordon RE, Stroes ES, Ma M, Farokhzad OC, Fayad ZA, Mulder WJ, Langer R. Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis. Proc Natl Acad Sci U S A 2014;111:1078-83. [PMID: 24395808 DOI: 10.1073/pnas.1322725111] [Cited by in Crossref: 125] [Cited by in F6Publishing: 96] [Article Influence: 17.9] [Reference Citation Analysis]
44 Schoenfeld SR, Lu L, Rai SK, Seeger JD, Zhang Y, Choi HK. Statin use and mortality in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis 2016;75:1315-20. [PMID: 26245753 DOI: 10.1136/annrheumdis-2015-207714] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 5.7] [Reference Citation Analysis]
45 Hang Y, Qin X, Ren T, Cao J. Baicalin reduces blood lipids and inflammation in patients with coronary artery disease and rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Lipids Health Dis 2018;17:146. [PMID: 29935544 DOI: 10.1186/s12944-018-0797-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
46 Teles R, Wang CY. Mechanisms involved in the association between periodontal diseases and cardiovascular disease. Oral Dis 2011;17:450-61. [PMID: 21223455 DOI: 10.1111/j.1601-0825.2010.01784.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 63] [Article Influence: 8.7] [Reference Citation Analysis]
47 Rodríguez-Carrio J, de Paz B, López P, Prado C, Alperi-López M, Ballina-García FJ, Suárez A. IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients. PLoS One 2014;9:e86069. [PMID: 24465874 DOI: 10.1371/journal.pone.0086069] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
48 Vemuganti R. Therapeutic Potential of PPARγ Activation in Stroke. PPAR Res 2008;2008:461981. [PMID: 21909480 DOI: 10.1155/2008/461981] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
49 Haque UJ, Bathon JM, Giles JT. Association of vitamin D with cardiometabolic risk factors in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64:1497-504. [PMID: 22555877 DOI: 10.1002/acr.21715] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
50 Veldhuijzen van Zanten JJ, Ring C, Carroll D, Kitas GD. Increased C reactive protein in response to acute stress in patients with rheumatoid arthritis. Ann Rheum Dis 2005;64:1299-304. [PMID: 15708880 DOI: 10.1136/ard.2004.032151] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
51 Balkrishna A, Sakat SS, Joshi K, Paudel S, Joshi D, Joshi K, Ranjan R, Gupta A, Bhattacharya K, Varshney A. Anti-Inflammatory and Anti-Arthritic Efficacies of an Indian Traditional Herbo-Mineral Medicine "Divya Amvatari Ras" in Collagen Antibody-Induced Arthritis (CAIA) Mouse Model Through Modulation of IL-6/IL-1β/TNF-α/NFκB Signaling. Front Pharmacol 2019;10:659. [PMID: 31333447 DOI: 10.3389/fphar.2019.00659] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
52 Summers GD, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol. 2010;6:445-451. [PMID: 20647995 DOI: 10.1038/nrrheum.2010.105] [Cited by in Crossref: 91] [Cited by in F6Publishing: 84] [Article Influence: 8.3] [Reference Citation Analysis]
53 Ahmed HM, Youssef M, Mosaad YM. Antibodies against oxidized low-density lipoprotein are associated with subclinical atherosclerosis in recent-onset rheumatoid arthritis. Clin Rheumatol. 2010;29:1237-1243. [PMID: 20354747 DOI: 10.1007/s10067-010-1436-0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
54 Pi H, Zhou H, Jin H, Ning Y, Wang Y. Abnormal Glucose Metabolism in Rheumatoid Arthritis. Biomed Res Int 2017;2017:9670434. [PMID: 28529957 DOI: 10.1155/2017/9670434] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
55 Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-1119. [PMID: 15864338 DOI: 10.1172/jci200525102] [Cited by in Crossref: 1182] [Article Influence: 73.9] [Reference Citation Analysis]
56 Khanna NN, Jamthikar AD, Gupta D, Piga M, Saba L, Carcassi C, Giannopoulos AA, Nicolaides A, Laird JR, Suri HS, Mavrogeni S, Protogerou AD, Sfikakis P, Kitas GD, Suri JS. Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning-Based Tissue Characterization. Curr Atheroscler Rep 2019;21:7. [PMID: 30684090 DOI: 10.1007/s11883-019-0766-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 14.5] [Reference Citation Analysis]
57 Bernelot Moens SJ, van der Valk FM, Strang AC, Kroon J, Smits LP, Kneepkens EL, Verberne HJ, van Buul JD, Nurmohamed MT, Stroes ES. Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study. Arthritis Res Ther 2016;18:115. [PMID: 27209093 DOI: 10.1186/s13075-016-1008-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
58 Lwin MN, Serhal L, Holroyd C, Edwards CJ. Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review. Rheumatol Ther 2020;7:457-71. [PMID: 32535834 DOI: 10.1007/s40744-020-00217-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
59 Charles-Schoeman C, Lee YY, Grijalva V, Amjadi S, FitzGerald J, Ranganath VK, Taylor M, McMahon M, Paulus HE, Reddy ST. Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis. 2012;71:1157-1162. [PMID: 22267330 DOI: 10.1136/annrheumdis-2011-200493] [Cited by in Crossref: 125] [Cited by in F6Publishing: 111] [Article Influence: 13.9] [Reference Citation Analysis]
60 Marder W, Khalatbari S, Myles JD, Hench R, Yalavarthi S, Lustig S, Brook R, Kaplan MJ. Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis. Ann Rheum Dis 2011;70:1550-5. [PMID: 21727237 DOI: 10.1136/ard.2010.148031] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
61 Sattar N, Murray HM, Mcconnachie A, Blauw GJ, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Murphy MB, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG, Shepherd J. C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Circulation 2007;115:981-9. [DOI: 10.1161/circulationaha.106.643114] [Cited by in Crossref: 91] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
62 Veselinovic M, Jakovljevic V, Jurisic-Skevin A, Toncev S, Djuric DM. Carotid enlargement and serum levels of von Willebrand factor in rheumatoid arthritis: a follow-up study. Clin Rheumatol 2012;31:1727-32. [PMID: 22960771 DOI: 10.1007/s10067-012-2079-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
63 Sari I, Karaoglu O, Can G, Akar S, Gulcu A, Birlik M, Akkoc N, Tunca M, Goktay Y, Onen F. Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 2007;26:1467-73. [PMID: 17242867 DOI: 10.1007/s10067-006-0529-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.6] [Reference Citation Analysis]
64 Cooney JK, Ahmad YA, Moore JP, Sandoo A, Thom JM. The impact of cardiorespiratory fitness on classical cardiovascular disease risk factors in rheumatoid arthritis: a cross-sectional and longitudinal study. Rheumatol Int 2019;39:1759-66. [PMID: 31482199 DOI: 10.1007/s00296-019-04431-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Labitigan M, Bahče-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, Putterman C, Broder A. Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2014;66:600-7. [PMID: 24115739 DOI: 10.1002/acr.22185] [Cited by in Crossref: 78] [Cited by in F6Publishing: 59] [Article Influence: 11.1] [Reference Citation Analysis]
66 Zhou M, Hou J, Zhong Z, Hao N, Lin Y, Li C. Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy. Drug Deliv 2018;25:716-22. [PMID: 29516758 DOI: 10.1080/10717544.2018.1447050] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
67 Alomari MA, Keewan EF, Shammaa RA, Alawneh K, Khatib SY, Welsch MA. Vascular function and handgrip strength in rheumatoid arthritis patients. ScientificWorldJournal 2012;2012:580863. [PMID: 22606051 DOI: 10.1100/2012/580863] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
68 Penesová A, Rádiková Z, Vlček M, Kerlik J, Lukáč J, Rovenský J, Imrich R. Chronic inflammation and low-dose glucocorticoid effects on glucose metabolism in premenopausal females with rheumatoid arthritis free of conventional metabolic risk factors. Physiol Res 2013;62:75-83. [PMID: 23173679 DOI: 10.33549/physiolres.932359] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
69 García-Bermúdez M, López-Mejías R, González-Juanatey C, Castañeda S, Miranda-Filloy JA, Blanco R, Fernández-Gutiérrez B, Balsa A, González-Alvaro I, Gómez-Vaquero C, Llorca J, Martín J, González-Gay MA. Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. DNA Cell Biol 2012;31:1214-20. [PMID: 22360682 DOI: 10.1089/dna.2011.1582] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
70 Ge Y, Zhou L, Chen Z, Mao Y, Li T, Tong P, Shan L. Identification of differentially expressed genes, signaling pathways and immune infiltration in rheumatoid arthritis by integrated bioinformatics analysis. Hereditas 2021;158:5. [PMID: 33397492 DOI: 10.1186/s41065-020-00169-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Wang SW, Lin TM, Wang CH, Liu HH, Houng JY. Increased toll-like receptor 2 expression in peptidoglycan-treated blood monocytes is associated with insulin resistance in patients with nondiabetic rheumatoid arthritis. Mediators Inflamm 2012;2012:690525. [PMID: 23213270 DOI: 10.1155/2012/690525] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
72 Najafi S, Rajaei E, Moallemian R, Nokhostin F. The potential similarities of COVID-19 and autoimmune disease pathogenesis and therapeutic options: new insights approach. Clin Rheumatol 2020;39:3223-35. [PMID: 32885345 DOI: 10.1007/s10067-020-05376-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
73 Crilly A, Palmer H, Nickdel MB, Dunning L, Lockhart JC, Plevin R, McInnes IB, Ferrell WR. Immunomodulatory role of proteinase-activated receptor-2. Ann Rheum Dis 2012;71:1559-66. [PMID: 22563031 DOI: 10.1136/annrheumdis-2011-200869] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
74 Veldhuijzen van Zanten JJ, Kitas GD. Inflammation, carotid intima-media thickness and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 2008;10:102. [PMID: 18226183 DOI: 10.1186/ar2345] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
75 Jamthikar AD, Gupta D, Puvvula A, Johri AM, Khanna NN, Saba L, Mavrogeni S, Laird JR, Pareek G, Miner M, Sfikakis PP, Protogerou A, Kitas GD, Kolluri R, Sharma AM, Viswanathan V, Rathore VS, Suri JS. Cardiovascular risk assessment in patients with rheumatoid arthritis using carotid ultrasound B-mode imaging. Rheumatol Int 2020;40:1921-39. [PMID: 32857281 DOI: 10.1007/s00296-020-04691-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
76 Deodhar A, Bitman B, Yang Y, Collier DH. The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis. Clin Rheumatol 2016;35:3045-52. [PMID: 27704313 DOI: 10.1007/s10067-016-3422-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
77 Burbano C, Rojas M, Muñoz-Vahos C, Vanegas-García A, Correa LA, Vásquez G, Castaño D. Extracellular vesicles are associated with the systemic inflammation of patients with seropositive rheumatoid arthritis. Sci Rep 2018;8:17917. [PMID: 30559453 DOI: 10.1038/s41598-018-36335-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 5.7] [Reference Citation Analysis]
78 Atzeni F, Corda M, Gianturco L, Porcu M, Sarzi-Puttini P, Turiel M. Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases. Front Med (Lausanne) 2018;5:26. [PMID: 29497612 DOI: 10.3389/fmed.2018.00026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
79 Dhawan SS, Quyyumi AA. Rheumatoid arthritis and cardiovascular disease. Curr Atheroscler Rep 2008;10:128-33. [PMID: 18417067 DOI: 10.1007/s11883-008-0019-x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
80 Huang JF, Wu QN, Zheng XQ, Sun XL, Wu CY, Wang XB, Wu CW, Wang B, Wang XY, Bergman M, Wu AM. The Characteristics and Mortality of Osteoporosis, Osteomyelitis, or Rheumatoid Arthritis in the Diabetes Population: A Retrospective Study. Int J Endocrinol 2020;2020:8821978. [PMID: 33224196 DOI: 10.1155/2020/8821978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Machin DR, Clifton HL, Garten RS, Gifford JR, Richardson RS, Wray DW, Frech TM, Donato AJ. Exercise-induced brachial artery blood flow and vascular function is impaired in systemic sclerosis. Am J Physiol Heart Circ Physiol 2016;311:H1375-81. [PMID: 27694218 DOI: 10.1152/ajpheart.00547.2016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
82 Greenberg JD, Furer V, Farkouh ME. Cardiovascular safety of biologic therapies for the treatment of RA. Nat Rev Rheumatol 2011;8:13-21. [PMID: 22083220 DOI: 10.1038/nrrheum.2011.168] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
83 Colmegna I, Diaz-Borjon A, Fujii H, Schaefer L, Goronzy JJ, Weyand CM. Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis. Arthritis Rheum 2008;58:990-1000. [PMID: 18383391 DOI: 10.1002/art.23287] [Cited by in Crossref: 69] [Cited by in F6Publishing: 63] [Article Influence: 5.3] [Reference Citation Analysis]
84 Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KM, Kitas GD. Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int 2011;31:153-64. [PMID: 20390282 DOI: 10.1007/s00296-010-1446-x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 8.7] [Reference Citation Analysis]
85 Caraba A, Crişan V, Romoşan I, Mozoş I, Murariu M. Vitamin D Status, Disease Activity, and Endothelial Dysfunction in Early Rheumatoid Arthritis Patients. Dis Markers 2017;2017:5241012. [PMID: 29200598 DOI: 10.1155/2017/5241012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
86 Bohensky M, Tacey M, Brand C, Sundararajan V, Wicks I, Van Doornum S. Statin initiation and treatment non-adherence following a first acute myocardial infarction in patients with inflammatory rheumatic disease versus the general population. Arthritis Res Ther 2014;16:443. [PMID: 25256139 DOI: 10.1186/s13075-014-0443-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
87 Sandoo A, Kitas GD, Carroll D, Veldhuijzen van Zanten JJ. The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study. Arthritis Res Ther 2012;14:R117. [PMID: 22594788 DOI: 10.1186/ar3847] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
88 Van Doornum S, Bohensky M, Tacey MA, Brand CA, Sundararajan V, Wicks IP. Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease. Arthritis Res Ther 2015;17:38. [PMID: 25879786 DOI: 10.1186/s13075-015-0552-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
89 Charles-Schoeman C, Watanabe J, Lee YY, Furst DE, Amjadi S, Elashoff D, Park G, McMahon M, Paulus HE, Fogelman AM, Reddy ST. Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum 2009;60:2870-9. [PMID: 19790070 DOI: 10.1002/art.24802] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 7.2] [Reference Citation Analysis]
90 Gómez-Vaquero C, Corrales A, Zacarías A, Rueda-Gotor J, Blanco R, González-Juanatey C, Llorca J, González-Gay MA. SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis. Arthritis Res Ther 2013;15:R91. [PMID: 23965231 DOI: 10.1186/ar4271] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 3.9] [Reference Citation Analysis]
91 Sandoo A, Protogerou AD, Hodson J, Smith JP, Zampeli E, Sfikakis PP, Kitas GD. The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study. Arthritis Res Ther 2012;14:R258. [PMID: 23190682 DOI: 10.1186/ar4103] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
92 Kim KO, Jang BI, Lee SH. Does carotid intima-media thickness increase in patients with inflammatory bowel disease? Intest Res. 2014;12:293-298. [PMID: 25374495 DOI: 10.5217/ir.2014.12.4.293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
93 Lin TT, Sung YL, Wu CE, Zhang H, Liu YB, Lin SF. Proarrhythmic risk and determinants of cardiac autonomic dysfunction in collagen-induced arthritis rats. BMC Musculoskelet Disord 2016;17:491. [PMID: 27894284 DOI: 10.1186/s12891-016-1347-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
94 Siebert S, Lyall DM, Mackay DF, Porter D, McInnes IB, Sattar N, Pell JP. Characteristics of rheumatoid arthritis and its association with major comorbid conditions: cross-sectional study of 502 649 UK Biobank participants. RMD Open 2016;2:e000267. [PMID: 27403335 DOI: 10.1136/rmdopen-2016-000267] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
95 Dixon WG, Symmons DP. What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology. Ann Rheum Dis 2007;66:1132-6. [PMID: 17251223 DOI: 10.1136/ard.2006.063867] [Cited by in Crossref: 84] [Cited by in F6Publishing: 78] [Article Influence: 6.0] [Reference Citation Analysis]
96 Klimek E, Skalska A, Kwaśny-Krochin B, Surdacki A, Sulicka J, Korkosz M, Fedak D, Kierzkowska I, Wizner B, Grodzicki TK. Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. Mediators Inflamm 2014;2014:681635. [PMID: 24864133 DOI: 10.1155/2014/681635] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
97 Hannawi SM, Hannawi H, Al Salmi I. Cardiovascular Risk in Rheumatoid Arthritis: Literature Review. Oman Med J 2021;36:e262. [PMID: 34164156 DOI: 10.5001/omj.2021.25] [Reference Citation Analysis]
98 Ozgen M, Koca SS, Aksoy K, Dagli N, Ustundag B, Isik A. Visfatin levels and intima-media thicknesses in rheumatic diseases. Clin Rheumatol 2011;30:757-63. [PMID: 21165753 DOI: 10.1007/s10067-010-1649-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
99 Manrique-Arija S, Mena-Vazquez N, Ureña I, Rioja J, Valdivielso P, Ginel-Mendoza L, Abad-Sánchez S, Jiménez-Núñez FG, Oliver-Martos B, Fernandez-Nebro A. Cumulative inflammatory burden and obesity as determinants of insulin resistance in patients with established rheumatoid arthritis: cross-sectional study. BMJ Open 2021;11:e044749. [PMID: 33563625 DOI: 10.1136/bmjopen-2020-044749] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
100 Dessein PH, Woodiwiss AJ, Norton GR, Solomon A. Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study. Arthritis Res Ther 2013;15:R96. [PMID: 23968456 DOI: 10.1186/ar4276] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
101 Dooley LM, Abdalmula A, Washington EA, Kaufman C, Tudor EM, Ghosh P, Itescu S, Kimpton WG, Bailey SR. Effect of mesenchymal precursor cells on the systemic inflammatory response and endothelial dysfunction in an ovine model of collagen-induced arthritis. PLoS One 2015;10:e0124144. [PMID: 25950840 DOI: 10.1371/journal.pone.0124144] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
102 Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 2011;70:482-7. [PMID: 21216812 DOI: 10.1136/ard.2010.135871] [Cited by in Crossref: 290] [Cited by in F6Publishing: 244] [Article Influence: 29.0] [Reference Citation Analysis]
103 Kim HJ, Kim MJ, Lee CK, Hong YH. Effects of Methotrexate on Carotid Intima-media Thickness in Patients with Rheumatoid Arthritis. J Korean Med Sci 2015;30:1589-96. [PMID: 26539002 DOI: 10.3346/jkms.2015.30.11.1589] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
104 Olsen AM, Fosbøl EL, Lindhardsen J, Folke F, Charlot M, Selmer C, Bjerring Olesen J, Lamberts M, Ruwald MH, Køber L. Long-term cardiovascular risk of nonsteroidal anti-inflammatory drug use according to time passed after first-time myocardial infarction: a nationwide cohort study. Circulation. 2012;126:1955-1963. [PMID: 22965337 DOI: 10.1161/circulationaha.112.112607] [Cited by in Crossref: 77] [Cited by in F6Publishing: 11] [Article Influence: 8.6] [Reference Citation Analysis]
105 Alemao E, Cawston H, Bourhis F, Al M, Rutten-van Molken M, Liao KP, Solomon DH. Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis. Rheumatology (Oxford) 2017;56:777-86. [PMID: 28087832 DOI: 10.1093/rheumatology/kew440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]
106 Bracht A, Silveira SS, Castro-Ghizoni CV, Sá-Nakanishi AB, Oliveira MR, Bersani-Amado CA, Peralta RM, Comar JF. Oxidative changes in the blood and serum albumin differentiate rats with monoarthritis and polyarthritis. Springerplus 2016;5:36. [PMID: 26835218 DOI: 10.1186/s40064-016-1671-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
107 Gierut A, Perlman H, Pope RM. Innate immunity and rheumatoid arthritis. Rheum Dis Clin North Am 2010;36:271-96. [PMID: 20510234 DOI: 10.1016/j.rdc.2010.03.004] [Cited by in Crossref: 75] [Cited by in F6Publishing: 60] [Article Influence: 6.8] [Reference Citation Analysis]
108 Kaplan MJ. Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment. Rheum Dis Clin North Am. 2010;36:405-426. [PMID: 20510241 DOI: 10.1016/j.rdc.2010.02.002] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 5.8] [Reference Citation Analysis]
109 van Eijk IC, Serné EH, Dijkmans BA, Smulders Y, Nurmohamed M. Microvascular function is preserved in newly diagnosed rheumatoid arthritis and low systemic inflammatory activity. Clin Rheumatol 2011;30:1113-8. [PMID: 21484221 DOI: 10.1007/s10067-011-1750-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
110 Turesson C, Jacobsson LT, Matteson EL. Cardiovascular co-morbidity in rheumatic diseases. Vasc Health Risk Manag 2008;4:605-14. [PMID: 18827910 DOI: 10.2147/vhrm.s2453] [Cited by in Crossref: 72] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
111 Niu X, Lu C, Xiao C, Zhang Z, Jiang M, He D, Bian Y, Zhang G, Bian Z, Lu A. The shared crosstalk of multiple pathways involved in the inflammation between rheumatoid arthritis and coronary artery disease based on a digital gene expression profile. PLoS One 2014;9:e113659. [PMID: 25514790 DOI: 10.1371/journal.pone.0113659] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
112 Zeller CB, Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev. 2008;4:116-122. [PMID: 19936286 DOI: 10.2174/157340308784245775] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
113 Sitia S, Gianturco L, Tomasoni L, Turiel M. Role of cardiovascular imaging in systemic autoimmune diseases. World J Cardiol 2010;2:237-42. [PMID: 21160590 DOI: 10.4330/wjc.v2.i8.237] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
114 Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol. 2015;11:693-704. [PMID: 26282082 DOI: 10.1038/nrrheum.2015.112] [Cited by in Crossref: 171] [Cited by in F6Publishing: 126] [Article Influence: 28.5] [Reference Citation Analysis]
115 Hsue PY, Scherzer R, Grunfeld C, Imboden J, Wu Y, Del Puerto G, Nitta E, Shigenaga J, Schnell Heringer A, Ganz P. Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis. J Am Heart Assoc. 2014;3:e001267. [PMID: 25336464 DOI: 10.1161/jaha.114.001267] [Cited by in Crossref: 31] [Cited by in F6Publishing: 16] [Article Influence: 4.4] [Reference Citation Analysis]
116 Welsh P, Grassia G, Botha S, Sattar N, Maffia P. Targeting inflammation to reduce cardiovascular disease risk: a realistic clinical prospect? Br J Pharmacol 2017;174:3898-913. [PMID: 28409825 DOI: 10.1111/bph.13818] [Cited by in Crossref: 90] [Cited by in F6Publishing: 71] [Article Influence: 22.5] [Reference Citation Analysis]
117 Acar A, Guzel S, Sarifakioglu B, Guzel EC, Guzelant AY, Karadag C, Kiziler L. Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment. Clin Rheumatol 2016;35:2685-92. [PMID: 27094943 DOI: 10.1007/s10067-016-3240-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
118 Brennan FM, McInnes IB. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest. 2008;118:3537-3545. [PMID: 18982160 DOI: 10.1172/jci36389] [Cited by in Crossref: 693] [Cited by in F6Publishing: 308] [Article Influence: 57.8] [Reference Citation Analysis]
119 Shin JH, Lee Y, Kim SG, Choi BY, Lee HS, Bang SY. The beneficial effects of Tai Chi exercise on endothelial function and arterial stiffness in elderly women with rheumatoid arthritis. Arthritis Res Ther 2015;17:380. [PMID: 26702640 DOI: 10.1186/s13075-015-0893-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
120 Mäki-Petäjä KM, Hall FC, Booth AD, Wallace SM, Yasmin PW, Harish S, Furlong A, McEniery CM, Brown J, Wilkinson IB. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation. 2006;114:1185-1192. [PMID: 16952987 DOI: 10.1161/circulationaha.105.601641] [Cited by in Crossref: 296] [Cited by in F6Publishing: 112] [Article Influence: 19.7] [Reference Citation Analysis]
121 Atzeni F, Rodríguez-Carrio J, Popa CD, Nurmohamed MT, Szűcs G, Szekanecz Z. Cardiovascular effects of approved drugs for rheumatoid arthritis. Nat Rev Rheumatol 2021;17:270-90. [PMID: 33833437 DOI: 10.1038/s41584-021-00593-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
122 Govindan KP, Basha S, Ramesh V, Kumar CN, Swathi S. A comparative study on serum lipoprotein (a) and lipid profile between rheumatoid arthritis patients and normal subjects. J Pharm Bioallied Sci 2015;7:S22-5. [PMID: 26015716 DOI: 10.4103/0975-7406.155767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
123 Bacchiega BC, Bacchiega AB, Usnayo MJ, Bedirian R, Singh G, Pinheiro GD. Interleukin 6 Inhibition and Coronary Artery Disease in a High-Risk Population: A Prospective Community-Based Clinical Study. J Am Heart Assoc 2017;6:e005038. [PMID: 28288972 DOI: 10.1161/JAHA.116.005038] [Cited by in Crossref: 64] [Cited by in F6Publishing: 38] [Article Influence: 16.0] [Reference Citation Analysis]
124 Zha AM, Di Napoli M, Behrouz R. Prevention of Stroke in Rheumatoid Arthritis. Curr Neurol Neurosci Rep 2015;15:77. [PMID: 26486791 DOI: 10.1007/s11910-015-0600-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
125 Gómez-Vaquero C, Robustillo M, Narváez J, Rodríguez-Moreno J, González-Juanatey C, Llorca J, Nolla JM, González-Gay MA. Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index. Clin Rheumatol 2012;31:35-9. [PMID: 21567119 DOI: 10.1007/s10067-011-1774-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
126 Pope JE, Nevskaya T, Barra L, Parraga G. Carotid Artery Atherosclerosis in Patients with Active Rheumatoid Arthritis: Predictors of Plaque Occurrence and Progression Over 24 Weeks. Open Rheumatol J 2016;10:49-59. [PMID: 27857821 DOI: 10.2174/1874312901610010049] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 3.4] [Reference Citation Analysis]
127 Schambelan M, Wilson PW, Yarasheski KE, Cade WT, Dávila-Román VG, D'Agostino RB Sr, Helmy TA, Law M, Mondy KE, Nachman S, Peterson LR, Worm SW; Working Group 5. Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. Circulation 2008;118:e48-53. [PMID: 18566316 DOI: 10.1161/CIRCULATIONAHA.107.189627] [Cited by in Crossref: 27] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
128 Wagan AA, Nasir S, Rahim A, Khan D. Impaired renal functions in Pakistani cohort of rheumatoid arthritis. Pak J Med Sci 2019;35:905-10. [PMID: 31372115 DOI: 10.12669/pjms.35.4.564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
129 Klimek E, Mikołajczyk T, Sulicka J, Kwaśny-Krochin B, Korkosz M, Osmenda G, Wizner B, Surdacki A, Guzik T, Grodzicki TK, Skalska A. Blood monocyte subsets and selected cardiovascular risk markers in rheumatoid arthritis of short duration in relation to disease activity. Biomed Res Int 2014;2014:736853. [PMID: 25126574 DOI: 10.1155/2014/736853] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
130 Virone A, Bastard JP, Fellahi S, Capeau J, Rouanet S, Sibilia J, Ravaud P, Berenbaum F, Gottenberg JE, Sellam J. Comparative effect of tumour necrosis factor inhibitors vs other biological agents on cardiovascular risk-associated biomarkers in patients with rheumatoid arthritis. RMD Open. 2019;5:e000897. [PMID: 31413865 DOI: 10.1136/rmdopen-2019-000897] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
131 Liakou AI, Zouboulis CC. Links and risks associated with psoriasis and metabolic syndrome. Psoriasis (Auckl) 2015;5:125-8. [PMID: 29387589 DOI: 10.2147/PTT.S54089] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
132 Jones G, Sebba A, Gu J, Lowenstein MB, Calvo A, Gomez-Reino JJ, Siri DA, Tomsic M, Alecock E, Woodworth T, Genovese MC. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Ann Rheum Dis. 2010;69:88-96. [PMID: 19297346 DOI: 10.1136/ard.2008.105197] [Cited by in Crossref: 508] [Cited by in F6Publishing: 402] [Article Influence: 46.2] [Reference Citation Analysis]
133 Velupillai YN, Packard CJ, Batty GD, Bezlyak V, Burns H, Cavanagh J, Deans K, Ford I, McGinty A, Millar K, Sattar N, Shiels P, Tannahill C. Psychological, social and biological determinants of ill health (pSoBid): study protocol of a population-based study. BMC Public Health 2008;8:126. [PMID: 18426568 DOI: 10.1186/1471-2458-8-126] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.6] [Reference Citation Analysis]
134 Lin TT, Wu CK, Liao MT, Yang YH, Chen PC, Yeih DF, Lin LY. Primary prevention of myocardial infarction with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertensive patients with rheumatoid arthritis-A nationwide cohort study. PLoS One 2017;12:e0188720. [PMID: 29216228 DOI: 10.1371/journal.pone.0188720] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
135 Symmons DP, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol. 2011;7:399-408. [PMID: 21629241 DOI: 10.1038/nrrheum.2011.75] [Cited by in Crossref: 230] [Cited by in F6Publishing: 178] [Article Influence: 23.0] [Reference Citation Analysis]
136 van den Oever IA, van Sijl AM, Nurmohamed MT. Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. Ther Adv Musculoskelet Dis 2013;5:166-81. [PMID: 23904862 DOI: 10.1177/1759720X13491025] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
137 Kang Y, Park HJ, Kang MI, Lee HS, Lee SW, Lee SK, Park YB. Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther 2013;15:R194. [PMID: 24245495 DOI: 10.1186/ar4384] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
138 Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111-1119. [PMID: 15864338 DOI: 10.1172/JCI200525102DS1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
139 Tian G, Liang JN, Wang ZY, Zhou D. Emerging role of leptin in rheumatoid arthritis. Clin Exp Immunol 2014;177:557-70. [PMID: 24802245 DOI: 10.1111/cei.12372] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
140 Solomon DH, Peters MJ, Nurmohamed MT, Dixon W. Unresolved questions in rheumatology: motion for debate: the data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritis. Arthritis Rheum 2013;65:1675-83. [PMID: 23606026 DOI: 10.1002/art.37975] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
141 Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Douglas KM, Kitas GD. Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. Rheumatol Int. 2011;31:153-164. [PMID: 20390282 DOI: 10.2174/138161211795049804] [Cited by in Crossref: 622] [Cited by in F6Publishing: 465] [Article Influence: 62.2] [Reference Citation Analysis]
142 Ismaili H, Ismaili L, Rexhepi M. Values and Correlations between C-Reactive Protein and Apolipoprotein B after Treatment with Methotrexate at Patients with Rheumatoid Arthritis. Open Access Maced J Med Sci 2019;7:1293-8. [PMID: 31110572 DOI: 10.3889/oamjms.2019.278] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
143 Totoson P, Maguin-Gaté K, Nappey M, Wendling D, Demougeot C. Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation. PLoS One 2016;11:e0146744. [PMID: 26761790 DOI: 10.1371/journal.pone.0146744] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 5.2] [Reference Citation Analysis]
144 Sinicato NA, da Silva Cardoso PA, Appenzeller S. Risk factors in cardiovascular disease in systemic lupus erythematosus. Curr Cardiol Rev 2013;9:15-9. [PMID: 23463953 DOI: 10.2174/157340313805076304] [Cited by in Crossref: 3] [Cited by in F6Publishing: 21] [Article Influence: 0.4] [Reference Citation Analysis]
145 Peru H, Altun B, Doğan M, Kara F, Elmaci AM, Oran B. The evaluation of carotid intima-media thickness in children with familial Mediterranean fever. Clin Rheumatol 2008;27:689-94. [PMID: 17926078 DOI: 10.1007/s10067-007-0764-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
146 El-Hini SH, Mohamed FI, Hassan AA, Ali F, Mahmoud A, Ibraheem HM. Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients. Rheumatol Int. 2013;33:2283-2289. [PMID: 23471745 DOI: 10.1007/s00296-013-2714-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
147 Mong N, Tarjanyi Z, Tothfalusi L, Bartykowszki A, Nagy AI, Szekely A, Becker D, Maurovich-Horvat P, Merkely B, Nagy G. Largely Accelerated Arterial Aging in Rheumatoid Arthritis Is Associated With Inflammatory Activity and Smoking in the Early Stage of the Disease. Front Pharmacol 2020;11:523962. [PMID: 33390933 DOI: 10.3389/fphar.2020.601344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
148 Chen DY, Chen YM, Hsieh TY, Hsieh CW, Lin CC, Lan JL. Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis. Arthritis Res Ther. 2015;17:52. [PMID: 25889426 DOI: 10.1186/s13075-015-0559-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
149 Peluso R, Caso F, Tasso M, Ambrosino P, Dario Di Minno MN, Lupoli R, Criscuolo L, Caso P, Ursini F, Puente AD, Scarpa R, Costa On Behalf Of CaRRDs Study Group L. Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients. Rev Recent Clin Trials 2018;13:199-209. [PMID: 29542417 DOI: 10.2174/1574887113666180314105511] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
150 Dixon WG, Watson KD, Lunt M, Hyrich KL, Silman AJ, Symmons DP. Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 2007;56:2905-2912. [PMID: 17763428 DOI: 10.1002/art.22809] [Cited by in Crossref: 392] [Cited by in F6Publishing: 311] [Article Influence: 28.0] [Reference Citation Analysis]
151 McInnes IB, Thompson L, Giles JT, Bathon JM, Salmon JE, Beaulieu AD, Codding CE, Carlson TH, Delles C, Lee JS. Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. Ann Rheum Dis. 2013;Epub ahead of print. [PMID: 24368514 DOI: 10.1136/annrheumdis-2013-204345] [Cited by in Crossref: 159] [Cited by in F6Publishing: 160] [Article Influence: 19.9] [Reference Citation Analysis]
152 Gabay C, McInnes IB, Kavanaugh A, Tuckwell K, Klearman M, Pulley J, Sattar N. Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis. Ann Rheum Dis 2016;75:1806-12. [PMID: 26613768 DOI: 10.1136/annrheumdis-2015-207872] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 13.3] [Reference Citation Analysis]
153 Ruscitti P, Di Benedetto P, Berardicurti O, Liakouli V, Carubbi F, Cipriani P, Giacomelli R. Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities. J Immunol Res 2018;2018:8410182. [PMID: 30584543 DOI: 10.1155/2018/8410182] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
154 Yilmazer B, Sahin T, Unlu BÖ, Kir HM, Cefle A. Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity. Rheumatol Int 2015;35:1385-92. [PMID: 25669439 DOI: 10.1007/s00296-015-3228-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
155 Fernández-Gutiérrez B, Perrotti PP, Gisbert JP, Domènech E, Fernández-Nebro A, Cañete JD, Ferrándiz C, Tornero J, García-Sánchez V, Panés J, Fonseca E, Blanco F, Rodríguez-Moreno J, Carreira P, Julià A, Marsal S, Rodriguez-Rodriguez L; IMID Consortium. Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts. Medicine (Baltimore) 2017;96:e7308. [PMID: 28658137 DOI: 10.1097/MD.0000000000007308] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
156 Kim W, Park S, Choi C, Kim YR, Park I, Seo C, Youn D, Shin W, Lee Y, Choi D, Kim M, Lee H, Kim S, Na C. Evaluation of Anti-Inflammatory Potential of the New Ganghwaljetongyeum on Adjuvant-Induced Inflammatory Arthritis in Rats. Evid Based Complement Alternat Med 2016;2016:1230294. [PMID: 27382402 DOI: 10.1155/2016/1230294] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
157 Fearon WF, Fearon DT. Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist. Circulation 2008;117:2577-9. [PMID: 18490534 DOI: 10.1161/CIRCULATIONAHA.108.772491] [Cited by in Crossref: 102] [Cited by in F6Publishing: 54] [Article Influence: 7.8] [Reference Citation Analysis]
158 Metsios GS, Stavropoulos-Kalinoglou A, Sandoo A, van Zanten JJ, Toms TE, John H, Kitas GD. Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. Open Cardiovasc Med J 2010;4:89-96. [PMID: 20361002 DOI: 10.2174/1874192401004020089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 21] [Article Influence: 0.2] [Reference Citation Analysis]
159 Davis JM, Knutson KL, Strausbauch MA, Crowson CS, Therneau TM, Wettstein PJ, Matteson EL, Gabriel SE. Analysis of complex biomarkers for human immune-mediated disorders based on cytokine responsiveness of peripheral blood cells. J Immunol. 2010;184:7297-7304. [PMID: 20495063 DOI: 10.4049/jimmunol.0904180] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
160 Wijbrandts CA, van Leuven SI, Boom HD, Gerlag DM, Stroes EG, Kastelein JJ, Tak PP. Sustained changes in lipid profile and macrophage migration inhibitory factor levels after anti-tumour necrosis factor therapy in rheumatoid arthritis. Ann Rheum Dis 2009;68:1316-21. [PMID: 18723565 DOI: 10.1136/ard.2007.086728] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.3] [Reference Citation Analysis]
161 Khattri S, Zandman-Goddard G. Statins and autoimmunity. Immunol Res 2013;56:348-57. [PMID: 23572428 DOI: 10.1007/s12026-013-8409-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 40] [Article Influence: 6.6] [Reference Citation Analysis]
162 Mankad R, Gabriel SE. Rheumatoid arthritis: treating cardiovascular risk in RA requires multidisciplinary care. Nat Rev Rheumatol 2014;10:202-4. [PMID: 24637364 DOI: 10.1038/nrrheum.2014.37] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
163 Marder W, Khalatbari S, Myles JD, Hench R, Lustig S, Yalavarthi S, Parameswaran A, Brook RD, Kaplan MJ. The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis. J Am Heart Assoc 2013;2:e000441. [PMID: 24252844 DOI: 10.1161/JAHA.113.000441] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
164 Popa CD, Arts E, Fransen J, van Riel PL. Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals. Mediators Inflamm 2012;2012:785946. [PMID: 22991486 DOI: 10.1155/2012/785946] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
165 Kuller LH, Mackey RH, Walitt BT, Deane KD, Holers VM, Robinson WH, Sokolove J, Chang Y, Liu S, Parks CG, Wright NC, Moreland LW. Determinants of mortality among postmenopausal women in the women's health initiative who report rheumatoid arthritis. Arthritis Rheumatol 2014;66:497-507. [PMID: 24574208 DOI: 10.1002/art.38268] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
166 Ljung L, Ueda P, Liao KP, Greenberg JD, Etzel CJ, Solomon DH, Askling J. Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation. RMD Open 2018;4:e000771. [PMID: 30622736 DOI: 10.1136/rmdopen-2018-000771] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
167 McCoy SS, Crowson CS, Maradit-Kremers H, Therneau TM, Roger VL, Matteson EL, Gabriel SE. Longterm outcomes and treatment after myocardial infarction in patients with rheumatoid arthritis. J Rheumatol 2013;40:605-10. [PMID: 23418388 DOI: 10.3899/jrheum.120941] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
168 Forsblad d'Elia H, Christgau S, Mattsson LA, Saxne T, Ohlsson C, Nordborg E, Carlsten H. Hormone replacement therapy, calcium and vitamin D3 versus calcium and vitamin D3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]. Arthritis Res Ther 2004;6:R457-68. [PMID: 15380045 DOI: 10.1186/ar1215] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
169 Hou L, Lloyd-Jones DM, Ning H, Huffman MD, Fornage M, He K, Zhang X, Jacobs DR, Goff DC, Sidney S, Carr JJ, Liu K. White blood cell count in young adulthood and coronary artery calcification in early middle age: coronary artery risk development in young adults (CARDIA) study. Eur J Epidemiol 2013;28:735-42. [PMID: 24030512 DOI: 10.1007/s10654-013-9842-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
170 Mozos I, Malainer C, Horbańczuk J, Gug C, Stoian D, Luca CT, Atanasov AG. Inflammatory Markers for Arterial Stiffness in Cardiovascular Diseases. Front Immunol 2017;8:1058. [PMID: 28912780 DOI: 10.3389/fimmu.2017.01058] [Cited by in Crossref: 121] [Cited by in F6Publishing: 87] [Article Influence: 30.3] [Reference Citation Analysis]
171 Özmen M, Yersal Ö, Öztürk S, Soysal D, Köseeoğlu MH. Prevalence of the metabolic syndrome in rheumatoid arthritis. Eur J Rheumatol 2014;1:1-4. [PMID: 27708861 DOI: 10.5152/eurjrheum.2014.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
172 Garg N, Krishan P, Syngle A. Atherosclerosis in Psoriatic Arthritis: A Multiparametric Analysis Using Imaging Technique and Laboratory Markers of Inflammation and Vascular Function. Int J Angiol 2016;25:222-8. [PMID: 27867287 DOI: 10.1055/s-0036-1584918] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
173 McInnes IB, McCarey DW, Sattar N. Do statins offer therapeutic potential in inflammatory arthritis? Ann Rheum Dis 2004;63:1535-7. [PMID: 15547075 DOI: 10.1136/ard.2004.022061] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
174 Ali A, Ali A, Kumar D, Kumar R, Elahi K, Suman F, Anjum Z, Tharwani P, Jahangir M, Rizwan A. Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus. Cureus 2021;13:e15716. [PMID: 34295575 DOI: 10.7759/cureus.15716] [Reference Citation Analysis]
175 Herrero-Beaumont G, Marcos ME, Sánchez-Pernaute O, Granados R, Ortega L, Montell E, Vergés J, Egido J, Largo R. Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis. Br J Pharmacol 2008;154:843-51. [PMID: 18536737 DOI: 10.1038/bjp.2008.113] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
176 Sandoo A, Hodson J, Douglas KM, Smith JP, Kitas GD. The association between functional and morphological assessments of endothelial function in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2013;15:R107. [PMID: 24010810 DOI: 10.1186/ar4287] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
177 Broide E, Schopan A, Zaretsky M, Kimchi NA, Shapiro M, Scapa E. Intima-media thickness of the common carotid artery is not significantly higher in Crohn’s disease patients compared to healthy population. Dig Dis Sci. 2011;56:197-202. [PMID: 20431949 DOI: 10.1007/s10620-010-1235-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
178 Parveen S, Jacob R, Rajasekhar L, Srinivasa C, Mohan IK. Serum Lipid Alterations in Early Rheumatoid Arthritis Patients on Disease Modifying Anti Rheumatoid Therapy. Indian J Clin Biochem 2017;32:26-32. [PMID: 28149009 DOI: 10.1007/s12291-016-0566-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
179 Douglas KM, Pace AV, Treharne GJ, Saratzis A, Nightingale P, Erb N, Banks MJ, Kitas GD. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis 2006;65:348-53. [PMID: 16079169 DOI: 10.1136/ard.2005.037978] [Cited by in Crossref: 97] [Cited by in F6Publishing: 81] [Article Influence: 6.1] [Reference Citation Analysis]
180 Nondahl DM, Cruickshanks KJ, Huang GH, Klein BE, Klein R, Nieto FJ, Tweed TS. Tinnitus and its risk factors in the Beaver Dam offspring study. Int J Audiol 2011;50:313-20. [PMID: 21309642 DOI: 10.3109/14992027.2010.551220] [Cited by in Crossref: 113] [Cited by in F6Publishing: 90] [Article Influence: 11.3] [Reference Citation Analysis]
181 Ren W, Wang M, Liao J, Li L, Yang D, Yao R, Huang L. The Effect of Chinese Herbal Medicine Combined With Western Medicine on Vascular Endothelial Function in Patients With Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Pharmacol 2020;11:823. [PMID: 32612527 DOI: 10.3389/fphar.2020.00823] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
182 Di Minno MN, Peluso R, Iervolino S, Russolillo A, Lupoli R, Scarpa R; CaRRDs Study Group. Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. Ann Rheum Dis 2014;73:1157-62. [PMID: 23771989 DOI: 10.1136/annrheumdis-2012-202812] [Cited by in Crossref: 119] [Cited by in F6Publishing: 79] [Article Influence: 14.9] [Reference Citation Analysis]
183 Listing J, Kekow J, Manger B, Burmester GR, Pattloch D, Zink A, Strangfeld A. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab. Ann Rheum Dis 2015;74:415-21. [PMID: 24291654 DOI: 10.1136/annrheumdis-2013-204021] [Cited by in Crossref: 137] [Cited by in F6Publishing: 107] [Article Influence: 17.1] [Reference Citation Analysis]
184 Summers CM, Hammons AL, Arora J, Zhang S, Jochems J, Blair IA, Whitehead AS. Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells. Eur J Pharmacol 2014;732:60-7. [PMID: 24657277 DOI: 10.1016/j.ejphar.2014.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
185 Verma I, Krishan P, Syngle A. Predictors of Atherosclerosis in Ankylosing Spondylitis. Rheumatol Ther 2015;2:173-82. [PMID: 27747533 DOI: 10.1007/s40744-015-0017-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
186 Srivastava NK, Sharma S, Sinha N, Mandal SK, Sharma D. Abnormal lipid metabolism in a rat model of arthritis: one possible pathway. Mol Cell Biochem 2018;448:107-24. [PMID: 29468503 DOI: 10.1007/s11010-018-3318-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
187 Amaya-Amaya J, Montoya-Sánchez L, Rojas-Villarraga A. Cardiovascular involvement in autoimmune diseases. Biomed Res Int 2014;2014:367359. [PMID: 25177690 DOI: 10.1155/2014/367359] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
188 Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-9. [PMID: 15864338 DOI: 10.1172/JCI25102] [Cited by in Crossref: 1398] [Cited by in F6Publishing: 1132] [Article Influence: 87.4] [Reference Citation Analysis]
189 Marks JL, Edwards CJ. Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity. Ther Adv Musculoskelet Dis 2012;4:149-57. [PMID: 22850632 DOI: 10.1177/1759720X11436239] [Cited by in Crossref: 32] [Cited by in F6Publishing: 13] [Article Influence: 3.6] [Reference Citation Analysis]
190 Hoffman E, Rahat MA, Feld J, Elias M, Rosner I, Kaly L, Lavie I, Gazitt T, Zisman D. Effects of Tocilizumab, an Anti-Interleukin-6 Receptor Antibody, on Serum Lipid and Adipokine Levels in Patients with Rheumatoid Arthritis. Int J Mol Sci 2019;20:E4633. [PMID: 31540528 DOI: 10.3390/ijms20184633] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
191 Wang X, Lou M, Li Y, Ye W, Zhang Z, Jia X, Shi H, Zhu X, Wang L. Cardiovascular involvement in connective tissue disease: the role of interstitial lung disease. PLoS One 2015;10:e0121976. [PMID: 25775471 DOI: 10.1371/journal.pone.0121976] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
192 Pasquini S, Contri C, Borea PA, Vincenzi F, Varani K. Adenosine and Inflammation: Here, There and Everywhere. Int J Mol Sci 2021;22:7685. [PMID: 34299305 DOI: 10.3390/ijms22147685] [Reference Citation Analysis]
193 Essouma M, Noubiap JJ. Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. Biomark Res 2015;3:24. [PMID: 26346508 DOI: 10.1186/s40364-015-0049-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
194 Watanabe J, Charles-Schoeman C, Miao Y, Elashoff D, Lee YY, Katselis G, Lee TD, Reddy ST. Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis. Arthritis Rheum 2012;64:1828-37. [PMID: 22231638 DOI: 10.1002/art.34363] [Cited by in Crossref: 103] [Cited by in F6Publishing: 91] [Article Influence: 11.4] [Reference Citation Analysis]
195 Direito R, Rocha J, Sepodes B, Eduardo-Figueira M. Phenolic Compounds Impact on Rheumatoid Arthritis, Inflammatory Bowel Disease and Microbiota Modulation. Pharmaceutics 2021;13:145. [PMID: 33499333 DOI: 10.3390/pharmaceutics13020145] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
196 Cooney JK, Law RJ, Matschke V, Lemmey AB, Moore JP, Ahmad Y, Jones JG, Maddison P, Thom JM. Benefits of exercise in rheumatoid arthritis. J Aging Res 2011;2011:681640. [PMID: 21403833 DOI: 10.4061/2011/681640] [Cited by in Crossref: 74] [Cited by in F6Publishing: 55] [Article Influence: 7.4] [Reference Citation Analysis]
197 Flammer AJ, Sudano I, Hermann F, Gay S, Forster A, Neidhart M, Künzler P, Enseleit F, Périat D, Hermann M, Nussberger J, Luscher TF, Corti R, Noll G, Ruschitzka F. Angiotensin-converting enzyme inhibition improves vascular function in rheumatoid arthritis. Circulation 2008;117:2262-9. [PMID: 18427133 DOI: 10.1161/CIRCULATIONAHA.107.734384] [Cited by in Crossref: 82] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
198 Solomon A, Tsang L, Woodiwiss AJ, Millen AM, Norton GR, Dessein PH. Cardiovascular disease risk amongst African black patients with rheumatoid arthritis: the need for population specific stratification. Biomed Res Int 2014;2014:826095. [PMID: 25157371 DOI: 10.1155/2014/826095] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
199 Sarmiento-Monroy JC, Amaya-Amaya J, Espinosa-Serna JS, Herrera-Díaz C, Anaya JM, Rojas-Villarraga A. Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america. Arthritis 2012;2012:371909. [PMID: 23193471 DOI: 10.1155/2012/371909] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
200 Glossop JR, Dawes PT, Nixon NB, Mattey DL. Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis. Arthritis Res Ther 2005;7:R1227-34. [PMID: 16277675 DOI: 10.1186/ar1816] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
201 Sandoo A, Chanchlani N, Hodson J, Smith JP, Douglas KM, Kitas GD. Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study. Arthritis Res Ther 2013;15:R203. [PMID: 24289091 DOI: 10.1186/ar4396] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
202 Chen J, Norling LV, Cooper D. Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation. Cells 2021;10:881. [PMID: 33924323 DOI: 10.3390/cells10040881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]